SBT-8230 | Interleukin Related interleukin-related.com

Product Name :
SBT-8230

Search keywords :
ASGPR

drugId :
null

Target Vo:
Toll like receptor 8

Target Vo Short Name :
TLR8

Moa_Name:
Toll like receptor 8 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Silverback Therapeutics Inc

Active Company_Name :
Silverback Therapeutics Inc

Active Indication_Name:
Hepatitis B

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IKB alpha Antibody
Gli1 Antibody
PI3 Kinase p110 gamma Antibody (YA690): PI3 Kinase p110 gamma Antibody (YA690) is a non-conjugated and Mouse origined monoclonal antibody about 126 kDa, targeting to PI3 Kinase p110 gamma (2D10). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts